Annual Total Long Term Liabilities
$8.81 M
-$3.57 M-28.83%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual total long term liabilities is currently $8.81 million, with the most recent change of -$3.57 million (-28.83%) on 31 December 2023. During the last 3 years, it has risen by +$8.81 million (+100.00%). NAMS annual total long term liabilities is now -28.83% below its all-time high of $12.37 million, reached on 31 December 2022.NAMS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$19.07 M
+$5.13 M+36.79%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly total long term liabilities is currently $19.07 million, with the most recent change of +$5.13 million (+36.79%) on 30 September 2024. NAMS quarterly long term liabilities is now at all-time high.NAMS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.8% | - |
| 3 y3 years | +100.0% | - |
| 5 y5 years | - | - |
NAMS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -28.8% | at high | >+9999.0% | |
| 5 y | 5 years | -28.8% | at high | >+9999.0% | |
| alltime | all time | -28.8% | at high | >+9999.0% |
NewAmsterdam Pharma Company NV Ordinary Shares Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.07 M(+36.8%) |
| June 2024 | - | $13.94 M(-17.7%) |
| Mar 2024 | - | $16.93 M(+92.3%) |
| Dec 2023 | $8.81 M | $8.81 M(-22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $11.41 M(-7.8%) |
| Dec 2022 | $12.37 M(+9744.1%) | $12.37 M(+57.3%) |
| June 2022 | - | $7.87 M(+6157.6%) |
| Dec 2021 | $125.70 K(>+9900.0%) | $125.70 K |
| Dec 2020 | $0.00 | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual total long term liabilities?
- What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual total long term liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual total long term liabilities?
The current annual total long term liabilities of NAMS is $8.81 M
What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual total long term liabilities is $12.37 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual total long term liabilities year-on-year change?
Over the past year, NAMS annual total long term liabilities has changed by -$3.57 M (-28.83%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total long term liabilities?
The current quarterly long term liabilities of NAMS is $19.07 M
What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly total long term liabilities is $19.07 M